As reported in Figure 3B, the rate of NDRG1 mutations was higher in the CDDP_EAGLE-1, EXCEPTIONAL_RESP, and TCGA-UCEC cohorts, including data from the Environment and Genetics in Lung Cancer Etiology study, patients with lasting clinical response, and uterine corpus endometrial carcinoma patients, respectively. This evidence concerns the gene NDRG1 and lung carcinoma.